imidazolium salt
Recently Published Documents


TOTAL DOCUMENTS

272
(FIVE YEARS 39)

H-INDEX

41
(FIVE YEARS 6)

2022 ◽  
Author(s):  
Xiaoqing Lv ◽  
Danyu Xia ◽  
Yujie Cheng ◽  
Jianbin Chao ◽  
Xuehong Wei ◽  
...  

An AB-type monomer based on a pillar[5]arene host and an imidazolium salt guest was successfully synthesized through a facile way. This monomer can self-assemble into linear supramolecular polymers in chloroform....


Author(s):  
Hamed Ghanbari ◽  
Katherine N. Robertson ◽  
Jason Clyburne ◽  
Ebrahim Soleimani

N-heterocyclic carbenes [1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene 1a (IMes) or 1,3-bis(2,6-di-iso-propylphenyl)imidazolidene 1b (SIPr)] react with the polarized alkenes 2 and 4 to form the crystalline betaines 3a, 3b and 5a. Furthermore, a one-pot reaction between an aldehyde, malonitrile, and an imidazolium salt of an N-heterocyclic carbene has been developed for the efficient preparation of betaine 5a without isolation of the free carbene. Full characterization data, including X-ray crystal structures, is reported for the three synthesized betaines. The structures of the betaines 3a, 3b and 5a shed new light on the initial products formed in the reactions between N-heterocyclic carbenes and compounds containing polarized double bonds.


2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Sumit Ghosh ◽  
Debashis Ghosh ◽  
Alakananda Hajra

Abstract An environmentally benign, stable yet efficient organocatalyst is highly desirable from the viewpoint of green chemistry and catalysis. Imidazole-based zwitterionic-type molten salts are a new type of organocatalysts with high catalytic application in various organic transformations with added advantage of room temperature ionic liquid (RTIL) property. Most importantly, these ionic-liquid catalysts are easily recyclable and subsequently reusable for multiple times without loss of significant catalytic efficiency. It has also been evident that C2–H of the imidazole has a vital role in catalyzing the reaction via electrophilic activation. Moreover, by changing the cations and/or anions, the properties of ILs can be tuned in many ways. In this article, the role of imidazolium zwitterionic molten salts as an organocatalyst for selective organic transformations including syn-selective aza-Henry reaction, Erlenmeyer reaction, synthesis of different heterocycles and their functionalization and regioselective ring-opening reactions has been elaborated chronically which will definitely be helping to the readers to explore this new class of organocatalyst for further applications.


Molbank ◽  
10.3390/m1280 ◽  
2021 ◽  
Vol 2021 (3) ◽  
pp. M1280
Author(s):  
Dorina Amăriucăi-Mantu ◽  
Violeta Mangalagiu ◽  
Catalina-Ionica Ciobanu ◽  
Vasilichia Antoci

We report here the design and synthesis of a new hybrid bis-anthracene-imidazolium salt, having a pyridine scaffold. NMR studies of dimer generation, as well as complexation with zinc acetate were performed.


2021 ◽  
Vol 57 (78) ◽  
pp. 10039-10042
Author(s):  
Fengkai He ◽  
Christophe Gourlaouen ◽  
Huan Pang ◽  
Pierre Braunstein

Whereas the bis(imine)imidazolium salt 1·Cl yielded with [Pt(cod)2] the PtII-hydrido NHC complex 3, the unprecedented, tetrahedral cluster [Pt4(μ-H)(cod)4]BF4 (7) was unexpectedly obtained from 1·BF4.


2020 ◽  
Vol 6 (4) ◽  
pp. 471-479
Author(s):  
Michael L. Stromyer ◽  
David J. Weader ◽  
Uttam Satyal ◽  
Philip H. Abbosh ◽  
Wiley J. Youngs

BACKGROUND: Bladder cancer is one of the most common types of cancer diagnosed each year, and more than half of patients have non-muscle invasive bladder cancer (NMIBC). The standard of care for patients with high-grade NMIBC is Bacillus Calmette-Guerin (BCG). Unfortunately, multiple BCG shortages have limited access to this treatment. Available alternatives using intravesical administration of chemotherapy have some efficacy, but lack prospective validation and long-term outcomes. Development of novel intravesical therapies may provide more active alternatives to BCG for patients with high-grade NMIBC. OBJECTIVE: To develop an optimal imidazolium salt for the intravesical treatment of NMIBC and determine preliminary in vitro activity of anthraquinone-substituted imidazolium salts. METHODS: The development of the anthraquinone-substituted imidazolium salts was undertaken in an attempt to increase the potency of this class of compounds by incorporating the quinone functional group observed in the chemotherapeutics doxorubicin, valrubicin, and mitomycin. All compounds were characterized by 1H and 13C NMR spectroscopy and infrared spectroscopy. Furthermore, these imidazolium salts were tested for in vitro cytotoxicity by the Developmental Therapeutics Program (DTP) on the NCI-60 human tumor cell line screening. Additional in vitro testing was performed against diverse bladder cancer cell lines (RT112, TCCSUP, J82, and UMUC13) using CellTiter-Glo® assays and colony-forming assays. RESULTS: The NCI-60 cell line screening indicated that compound 7 had the highest activity and was concluded to be the optimal compound for further study. Using CellTiter-Glo® assays on bladder cancer cell lines, 50% growth inhibitory concentration (IC50) values were determined to range from 32–50μM after an exposure of 1 h, for compound 7. Further evaluation of the compound by colony-forming assays showed the complete inhibition of growth at 10 days post a 100μM dose of compound 7 for 1 h. CONCLUSIONS: The most active lipophilic anthraquinone imidazolium salt, compound 7, could be a viable treatment for non-muscle invasive bladder cancer as it exhibits a cell-killing effect at a 1 h time period and completely inhibits cancer regrowth in colony-forming assays.


Author(s):  
Rajarshi Mondal ◽  
Robert J. Ortiz ◽  
Jason D. Braun ◽  
David E. Herbert

An N-heterocyclic carbene ligand precursor bearing a π-extended phenanthridine (3,4-benzoquinoline) unit is presented. The proligand was isolated as the imidazolium salt of chloride (1•HCl), bromide (1•HBr) or hexafluorophosphate (1•HPF6) counterions. These salts can be deprotonated and the carbene installed on silver centres using Ag2O as both a base and a source of metal ion. The resulting Ag(I) complex (1)AgCl can be used in a transmetalation reaction to generate a Pd(II) coordination complex (1)Pd(CH3CN)Cl2. The characterization and photophysical properties of these complexes is presented, along with a demonstration of the utility of (1)Pd(CH3CN)Cl2 in mediating a catalytic C-N cross-coupling reaction for the preparation of the pharmaceutical Piribedil.


Sign in / Sign up

Export Citation Format

Share Document